Search research articles
Contact Us
Filters
Showing results (271-280 of 296) with videos related to
Page
of 30
Sort By:
Cancer Research Communications
|
August 29, 2024
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer
Matthew T Campbell, Amishi Y Shah, Pavlos Msaouel, et al.
The New England Journal of Medicine
|
January 31, 2024
CRISPR-Cas9 In Vivo Gene Editing of <i>KLKB1</i> for Hereditary Angioedema
Hilary J Longhurst, Karen Lindsay, Remy S Petersen, et al.
Molecular Cancer Research : MCR
|
December 16, 2020
Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, et al.
Nature Communications
|
November 5, 2021
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma
Matthew T Campbell, Surena F Matin, Alda L Tam, et al.
JAMA Network Open
|
August 30, 2021
Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors
Pavlos Msaouel, Clara Oromendia, Arlene O Siefker-Radtke, et al.
Cancer Discovery
|
September 5, 2013
Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment
Masato Nishimura, Eun-Jung Jung, Maitri Y Shah, et al.
European Urology
|
March 1, 2026
KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model
Chad Tang, Aaron Seo, Alexander D Sherry, et al.
European Urology Oncology
|
October 13, 2023
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract
Omar Alhalabi, Nathaniel Wilson, Lianchun Xiao, et al.
Nature Communications
|
May 10, 2023
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma
Jose A Karam, Pavlos Msaouel, Cara L Haymaker, et al.
Nature Communications
|
January 10, 2025
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial
Pavlos Msaouel, Kai Yu, Ying Yuan, et al.
Page
of 30
Search research articles
Search
Showing results (271-280 of 296) with videos related to
Sort By:
Page
of 30
Cancer Research Communications
|
August 29, 2024
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer
Matthew T Campbell, Amishi Y Shah, Pavlos Msaouel, et al.
The New England Journal of Medicine
|
January 31, 2024
CRISPR-Cas9 In Vivo Gene Editing of <i>KLKB1</i> for Hereditary Angioedema
Hilary J Longhurst, Karen Lindsay, Remy S Petersen, et al.
Molecular Cancer Research : MCR
|
December 16, 2020
Molecular Profiling of Metastatic Bladder Cancer Early-Phase Clinical Trial Participants Predicts Patient Outcomes
Omar Alhalabi, Andrew W Hahn, Pavlos Msaouel, et al.
Nature Communications
|
November 5, 2021
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma
Matthew T Campbell, Surena F Matin, Alda L Tam, et al.
JAMA Network Open
|
August 30, 2021
Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors
Pavlos Msaouel, Clara Oromendia, Arlene O Siefker-Radtke, et al.
Cancer Discovery
|
September 5, 2013
Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment
Masato Nishimura, Eun-Jung Jung, Maitri Y Shah, et al.
European Urology
|
March 1, 2026
KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model
Chad Tang, Aaron Seo, Alexander D Sherry, et al.
European Urology Oncology
|
October 13, 2023
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract
Omar Alhalabi, Nathaniel Wilson, Lianchun Xiao, et al.
Nature Communications
|
May 10, 2023
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma
Jose A Karam, Pavlos Msaouel, Cara L Haymaker, et al.
Nature Communications
|
January 10, 2025
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial
Pavlos Msaouel, Kai Yu, Ying Yuan, et al.
Page
of 30